<?xml version="1.0" encoding="UTF-8"?>
<p id="P17">CC-486 treatment continued until unacceptable toxicity, disease relapse or progression, development of grades III to IV acute or severe chronic GVHD, consent withdrawal, death, or until a maximum of 12 CC-486 cycles had been administered.</p>
